|
The MHRA is the first European regulator to give Foundayo a regulatory blessing, with the drug still under review by the EU.
|
 |
|
This will establish BMS’ in-house manufacturing presence in Texas, adding to its ongoing outlicensing and research partnerships in the state.
|
|
|
As part of the deal, Actio Biosciences will spin out a new company focused on genetic rare neurological diseases.
|
|
|
The partnership will focus on developing combination therapies for patients with RAS-addicted cancers.
|
|
|
Experts predict that DHTs such as wearables and health apps will play a burgeoning role in obesity research and care, though barriers to equitable access remain.
|
|
